# FDA Inspection 1181263 - Axolotl Biologix, Inc. - September 29, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/axolotl-biologix-inc/ff019993-cbc8-4e03-8141-d9fdb8364f78/
Source feed: FDA_Inspections

> FDA Inspection 1181263 for Axolotl Biologix, Inc. on September 29, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181263
- Company Name: Axolotl Biologix, Inc.
- Inspection Date: 2022-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181263 - 2022-09-29](https://www.globalkeysolutions.net/api/records/fda_inspections/axolotl-biologix-inc/9a4cc857-c77d-4359-b24b-47b4d96bc7bb/)
- [FDA Inspection 1181263 - 2022-09-29](https://www.globalkeysolutions.net/api/records/fda_inspections/axolotl-biologix-inc/117b3140-3238-4ee9-b228-88377e319306/)
- [FDA Inspection 1026690 - 2017-08-04](https://www.globalkeysolutions.net/api/records/fda_inspections/axolotl-biologix-inc/aa28cb54-da75-4a5f-abbc-9f1ddd667bb5/)
- [FDA Inspection 1026690 - 2017-08-04](https://www.globalkeysolutions.net/api/records/fda_inspections/axolotl-biologix-inc/4597924b-206e-4f30-895a-1fb41e199316/)

Company: https://www.globalkeysolutions.net/companies/axolotl-biologix-inc/3ba40e89-e411-499e-ad79-3e54d1d2e8ae

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d